Immunocore Holdings (IMCR) Stock Statistics & Valuation Metrics

Immunocore Holdings has a market cap or net worth of $1.99B. The enterprise value is $1.37B.

Immunocore Holdings has 50,530,420 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunocore Holdings’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -8.51%.

The current PE Ratio of Immunocore Holdings is ―. Immunocore Holdings’s PEG ratio is 2.97.

In the last 12 months, Immunocore Holdings had revenue of 247.77M and earned -40.81M in profits. Earnings per share was -1.02.

In the last 12 months, operating cash flow was 7.99M and capital expenditures -5.04M, giving a free cash flow of 2.95M billion.

Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Immunocore Holdings upcoming earnings date is Mar 4, 2026, Before Open (Confirmed).

Immunocore Holdings as a current ratio of 4.38, with Debt / Equity ratio of 10.91%

In the past 12 months, Immunocore Holdings has paid -1.48M in taxes.

Immunocore Holdings EV to EBITDA ratio is -37.70, with an EV/FCF ratio of 69.50.

Immunocore Holdings has $892.35M in cash and marketable securities with $43.27M in debt, giving a net cash position of $849.08M billion.

Gross margin is 99.29%, with operating margin of -22.71%, and net profit margin of -16.47%.

The average price target for Immunocore Holdings is $65.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy